These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16940847)

  • 1. Pertussis vaccine effectiveness in reducing clinical disease, transmissibility and proportion of cases with a positive culture after household exposure in Brazil.
    Baptista PN; Magalhães V; Rodrigues LC; Rocha MW; Pimentel AM
    Pediatr Infect Dis J; 2006 Sep; 25(9):844-6. PubMed ID: 16940847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of adults in household outbreaks of pertussis.
    Baptista PN; Magalhães VS; Rodrigues LC
    Int J Infect Dis; 2010 Feb; 14(2):e111-4. PubMed ID: 19559636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients.
    Isomura S; Suzuki S; Sato Y
    Dev Biol Stand; 1985; 61():531-7. PubMed ID: 3914964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity.
    Préziosi MP; Halloran ME
    Clin Infect Dis; 2003 Sep; 37(6):772-9. PubMed ID: 12955637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis--New Zealand 1982/83.
    Begg RC
    N Z Med J; 1984 Jun; 97(758):408-11. PubMed ID: 6589532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the analysis of secondary prevention of pertussis.
    Wirsing von König CH; Schmitt HJ; Bogaerts H; Bock HL; Laukamp S; Kiederle S; Postels-Multani S
    Dev Biol Stand; 1997; 89():175-9. PubMed ID: 9272349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis disease burden in the household: how to protect young infants.
    de Greeff SC; Mooi FR; Westerhof A; Verbakel JM; Peeters MF; Heuvelman CJ; Notermans DW; Elvers LH; Schellekens JF; de Melker HE
    Clin Infect Dis; 2010 May; 50(10):1339-45. PubMed ID: 20370464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has the change to acellular pertussis vaccine improved or worsened pertussis control?
    Halperin SA; De Serres G
    CMAJ; 2006 Nov; 175(10):1227. PubMed ID: 17098952
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A field study of household attack rates and the effectiveness of macrolide antibiotics in reducing household transmission of pertussis.
    Terry JB; Flatley CJ; van den Berg DJ; Morgan GG; Trent M; Turahui JA; Greenwood MC; Corben PW; Bell GJ
    Commun Dis Intell Q Rep; 2015 Mar; 39(1):E27-33. PubMed ID: 26063095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A countywide outbreak of pertussis: initial transmission in a high school weight room with subsequent substantial impact on adolescents and adults.
    Sotir MJ; Cappozzo DL; Warshauer DM; Schmidt CE; Monson TA; Berg JL; Zastrow JA; Gabor GW; Davis JP
    Arch Pediatr Adolesc Med; 2008 Jan; 162(1):79-85. PubMed ID: 18180417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of acellular pertussis vaccination during childhood (<7 years of age) for preventing pertussis in household contacts 1-9 years old in Catalonia and Navarra (Spain).
    Plans P; Toledo D; Sala MR; Camps N; Villanova M; Rodríguez R; Alvarez J; Solano R; García-Cenoz M; Barrabeig I; Godoy P; Minguell S
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):2059-2067. PubMed ID: 27612470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pertussis in 1997].
    Tomaszunas-Błaszczyk J
    Przegl Epidemiol; 1999; 53(1-2):23-32. PubMed ID: 10402846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against pertussis by Takeda's acellular pertussis vaccine: household contact studies in Kawasaki City, Japan.
    Kato T; Kaku H; Arimoto Y
    Tokai J Exp Clin Med; 1988; 13 Suppl():35-8. PubMed ID: 3078808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis-the case for universal vaccination.
    Rittle C
    J Spec Pediatr Nurs; 2010 Oct; 15(4):282-91. PubMed ID: 20880276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the vaccination coverage established enough to control pertussis, or it is a re-emerging disease?
    Cardeñosa N; Romero M; Quesada M; Oviedo M; Carmona G; Codina G; Jansà JM; Domínguez A;
    Vaccine; 2009 May; 27(25-26):3489-91. PubMed ID: 19200822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the spread of pertussis in households: a prospective study, Catalonia and Navarre, Spain, 2012 to 2013.
    Godoy P; García-Cenoz M; Toledo D; Carmona G; Caylà JA; Alsedà M; Àlvarez J; Barrabeig I; Camps N; Plans P; Company M; Castilla J; Sala-Farré MR; Muñoz-Almagro C; Rius C; Domínguez À;
    Euro Surveill; 2016 Nov; 21(45):. PubMed ID: 27918260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis. Presentation, investigation and management.
    Frydenberg A; Starr M
    Aust Fam Physician; 2004 May; 33(5):317-9. PubMed ID: 15227860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bordetella pertussis infection in a highly vaccinated population in Saudi Arabia, 1996-2004.
    Al-Tawfiq JA; AbuKhamsin A
    J Infect; 2007 Sep; 55(3):249-53. PubMed ID: 17568679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.